Drug Type Chemical drugs |
Synonyms ALTO 330 |
Mechanism 5-HT2C receptor modulators(Serotonin 2c (5-HT2c) receptor modulators), MTNR1A modulators(Melatonin receptor 1A modulators), MTNR1B agonists(Melatonin receptor 1B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Preclinical | US | Alto Neuroscience, Inc.Startup | 30 Jan 2024 |